操作和完整性

At AbbVie, all employees are expected to lead and foster a culture of ethical and compliant behavior. To assist us, AbbVie has an Office of Ethics and Compliance (OEC), which focuses on the development and enhancement of our compliance program. OEC is led by our Chief Ethics and Compliance Officer (CECO), who is a member of our senior management and makes regular reports regarding compliance matters to the Chairman of the Board and Chief Executive Officer, other senior-level leaders and AbbVie’s Board of Directors and Public Policy and Sustainability Committee. The OEC staff provides dedicated support to AbbVie’s leaders, employees and businesses.
\r\n
\r\nTo assist in the implementation of the compliance program, AbbVie has a Global Compliance Insights Forum (GCIF) focused on our Global Compliance Program. The GCIF is chaired by the CECO, includes senior-level leaders, and is accountable directly to the Chairman of the Board and Chief Executive Officer. Periodic GCIF meetings are held to discuss compliance matters, including adherence to legal and regulatory obligations and commitments, assessment of our compliance program, changes in the legal and regulatory environment, risk areas and best practices, and improvements to the program.
\r\n
\r\nOutside the United States, our Affiliate Compliance Program is managed by local Affiliate Compliance Committees, which are composed of the General Manager and other top executives within a country. Working with OEC staff, the Affiliate Compliance Committees are responsible for the day-to-day function of the compliance program, including monitoring of compliance, providing awareness of and training for the program, revising policies and procedures and providing guidance to local employees. The committees meet on a regular basis to discuss emerging issues and work with the OEC staff as new compliance and awareness programs are rolled out. Compliance professionals are located throughout the world and provide oversight and guidance to the Affiliate Compliance Committees.

\r\n"}}" id="text-496ef52cbf" class="cmp-text">

在AbbVie,所有员工将铅和培育一种伦理和文化兼容的行为。协助我们,AbbVie有道德与合规办公室(OEC),专注于开发和增强我们的合规程序。狗万正网地址OEC是由我们的道德与合规总监(CECO),谁是我们的高级管理层,让成员定期报告关于合规事项的董事会主席和首席执行官,其他高层领导人和AbbVie董事会和公共政策和可持续发展委员会。OEC人员提供专门支持AbbVie的领导人,员工和企业。

协助合规计划的实现,AbbVie有全球合规见解论坛(GCIF)专注于我们的全球合规程序。GCIF CECO主持的,包括高层领导人,负责直接向董事会主席和首席执行官。周期性GCIF举行会议讨论合规事务,包括遵守法律和监管义务和承诺,评估我们的合规程序,法律和监管环境的变化,风险区域和最佳实践,改进计划。

美国以外,我们的分公司合规计划由当地分公司合规管理委员会,由总经理和其他高管在一个国家。工作描述:员工、下属合规委员会负责日常合规计划的功能,包括合规监测,提供的意识和培训计划,修订的政策和程序,并为本地员工提供指导。委员会定期开会讨论新出现的问题和工作描述:员工推出新的合规意识项目。合规专业人士遍布世界,提供监督和指导分公司合规委员会。

The Code of Business Conduct, published in print and online, sets forth core guidelines and requirements for ethical behavior. AbbVie employees read and certify adherence to our Code annually. Our Code states clearly that AbbVie does not tolerate illegal or unethical behavior in any aspect of our business. It emphasizes the importance of ethical and honest conduct, adhering to AbbVie’s policies and procedures, treating confidential information appropriately, avoiding conflicts of interest and maintaining AbbVie’s books and records with accuracy and integrity. Further, it requires our employees to ask questions about or report any concerns regarding compliance matters.
\r\n
\r\nIn addition to our Code, we have policies and procedures that guide employees as they conduct their day-to-day activities. They encompass relevant laws and regulations, including food and drug laws and laws relating to government health care programs. They also take into account industry best practices, including provisions of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Code of Pharmaceutical Marketing Practices and the Pharmaceutical Research and Manufacturers of America’s (PhRMA) Code on Interactions with Health Care Professionals, as well as other applicable industry codes. We regularly update our policies to incorporate changes to the law and industry codes, including rules regarding gifts, meals and education we provide to health care professionals.
\r\n
\r\nAbbVie also complies with legal, industry and relevant institutions’ requirements regarding the interaction of our employees with health care professionals and organizations. We comply with national, regional, state and other requirements regarding transparency about our relationships with individuals and entities involved in providing health care. As required, we track and report payments and transfers of value (such as meals) provided to health care providers and organizations.
\r\n

\r\n"}}" id="text-8798216296" class="cmp-text">

代码的商业行为,在印刷和在线出版,阐述核心道德行为准则和要求。AbbVie员工阅读并证明每年坚持我们的代码。我们的代码明确指出,AbbVie不容忍非法或不道德的行为在任何方面我们的业务。它强调道德和诚实的行为的重要性,坚持AbbVie的政策和程序,适当处理机密信息,避免利益冲突和维护AbbVie书籍和记录的准确性和完整性。进一步,它要求我们的员工问问题或报告任何问题关于合规问题。

除了我们的代码,我们有政策和程序,指导员工进行日常活动。它们包含有关法律、法规,包括食品和药品相关法律和法律政府医疗保健项目。他们还考虑业界最佳实践,包括规定国际制药厂商协会联合会联合会代码医药营销实践和美国药品研究与制造商的制造商代码与卫生保健专业人员的互动,以及其他适用的行业规范。我们定期更新我们的政策将改变法律和行业规范,包括规则关于礼物,饮食和教育我们提供卫生保健专业人士。

AbbVie也符合法律、行业和相关机构的要求关于我们的员工之间的相互作用与卫生保健专业人员和组织。我们遵守国家、地区、州和其他有关透明度的要求对我们的关系个人和实体提供卫生保健。根据需要,我们跟踪和报告支付和转移的价值(如食物)提供卫生保健提供者和组织。

Creating an environment where employees can raise questions and concerns helps us advance our commitment to ethical behavior. We have established systems and processes for employees and others to ask questions, raise concerns and report suspected or actual violations of our Code, policies and procedures, or laws and regulations, without fear of retribution or retaliation. We offer a Global Helpline Portal available 24 hours a day, seven days a week. Employees also may contact the Office of Ethics and Compliance (OEC) or the Chief Ethics and Compliance Officer (CECO) directly. Select the link for information on our Ethics and Compliance Helpline Privacy Notice.
\r\n
\r\nAll allegations are analyzed and corrective actions are taken where necessary, including terminating employees or supplier relationships. In accordance with our internal or legal obligations, we report information about actual or potential violations to senior management, the Board and the government(s), as appropriate. The OEC also creates opportunities to engage in face-to-face interactions with employees by participating in national, regional and local meetings.

\r\n"}}" id="text-05f684ed53" class="cmp-text">

创建一个环境,让员工可以提出问题和担忧帮助我们促进我们对道德行为的承诺。我们建立了系统和流程对员工和其他人问问题,提出问题和报告疑似或实际违反我们的代码,政策和程序,或法律法规,而不必担心报复或报复。我们提供全球服务热线门户提供一天24小时,一周7天。员工也可以联系道德与合规办公室(OEC)或道德与合规总监直接(CECO)。选择的链接信息道德与合规热线隐私通知。

所有的指控都是分析并在必要时采取纠正措施,包括解雇员工或供应商关系。按照我们的内部或法律义务,我们报告实际或潜在违规信息高级管理人员、董事会和政府(s)。OEC也创造了机会与员工进行面对面的交互通过参与国家、地区和地方会议。

Training and education programs for employees and other relevant personnel increase their awareness of our Code’s precepts and the legal and ethical implications of their actions and behaviors. AbbVie’s ethics and compliance staff work with our local commercial teams throughout the world to help them conduct trainings and education programs that help ensure compliance and strengthen AbbVie’s reputation as a responsible corporate citizen while enhancing relationships with customers and other stakeholders.
\r\n
\r\nFor example, employees in the United States, Puerto Rico and Latin America participate in our Legal and Ethics Resource Network program, a web-based training system designed to increase awareness of policies and procedures, as well as the legal and ethical implications of business decisions. Another successful approach has been the use of interactive ethics challenge games, in which local employees meet face-to-face with OEC representatives to ask questions and discuss company policies.
\r\n

\r\n"}}" id="text-77dc9f0ab4" class="cmp-text">

为员工培训和教育项目和其他相关人员提高他们对我们的代码的戒律和法律和伦理的影响他们的行为和行为。AbbVie道德与合规工作人员与我们当地的商业团队在整个世界来帮助他们进行培训和教育项目,帮助确保遵从性和加强AbbVie的声誉作为一个负责任的企业公民,同时加强与客户和其他利益相关者的关系。

例如,员工在美国,波多黎各和拉丁美洲参与我们的法律和道德资源网络计划,一个基于网络的培训体系,旨在提高认识,政策和程序,以及法律和伦理的影响业务决策。成功的另一个方法是使用交互式伦理挑战游戏,在当地员工面对面的会见OEC代表提问和讨论公司政策。

AbbVie employees and other relevant personnel are expected to adhere to our Code as a condition of their continued employment. Anyone who violates our Code, or any policy or procedure, is subject to appropriate disciplinary action. Any AbbVie employee who fails to report a violation of AbbVie policy or procedure of which he or she is or should have been aware may also be subject to disciplinary action. AbbVie does not tolerate retaliation against anyone who makes a good-faith report regarding a violation or potential violation of our Code, policies or procedures, or laws or regulations. These guidelines are well publicized and enforced.

\r\n"}}" id="text-3ebb98992b" class="cmp-text">

AbbVie员工和其他相关人员预计将坚持我们的代码作为他们继续就业的条件。任何人违反了我们的代码,或任何政策或程序,受到相应的纪律处分。任何AbbVie员工未能报告违反AbbVie政策或程序,他或她应该是知道也可能受到纪律处分。AbbVie不容忍报复那些让善意报告关于违反或可能违反我们的代码,政策或程序,或法律、法规。宣传和实施这些准则。

The OEC utilizes results from internal investigations, internal audits and internal monitoring programs to assess the effectiveness of, and identify areas for improvement in, the compliance program and relevant business practices. In addition, we consider the external environment, including government investigations, settlements, industry codes and government guidance to identify new opportunities to enhance the compliance program.

\r\n"}}" id="text-bddd29172d" class="cmp-text">

OEC利用内部调查的结果,内部审计和内部监控程序评估的有效性,并确定改进的区域,合规程序和相关的业务实践。另外,我们考虑到外部环境,包括政府调查,定居点,行业规范和政府指导识别新的机会来增强合规项目。

Results of investigations, audits and monitoring are communicated to the appropriate OEC staff and business leaders. When an area for improvement is identified, the OEC and other AbbVie functions partner to implement corrective actions.

\r\n"}}" id="text-7031f0e4c0" class="cmp-text">

调查的结果,审计和监控已经传达到适当的描述:员工和商业领袖。当一个确定改进的区域,OEC和其他AbbVie功能合作伙伴实施纠正措施。